Eosinophilic Granulomatosis with Polyangiitis Relapse after COVID-19 Vaccination: A Case ReportCase Report Published on 2021-12-232022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] clinical response COVID-19 diagnosed Dyspnea EGPA Eosinophilic first dose granulomatosis limb mepolizumab Mild monoclonal antibody mRNA BNT162b2 vaccine myalgia occurred polyangiitis Relapse report SARS-COV-2 infection tested treated Treatment Vaccine [DOI] 10.3390/vaccines10010013 PMC 바로가기 [Article Type] Case Report
Olfactory dysfunction as a screening tool for mild and moderate cases of COVID-19: a single-center prevalence study of 646 patients in flu clinicOriginal Article Published on 2021-12-202022-10-31 Journal: The Egyptian Journal of Otolaryngology [Category] COVID-19, [키워드] affected age analyzed Anosmia association calculate carried co-morbidity Contact cough COVID-19 COVID-19 infection COVID-19 patients diarrhea dysfunction evaluate female Fever flu Gustatory identify laboratory-confirmed malaise male Mild moderate myalgia nasal olfactory dysfunction Patient patients positive Prevalence prevalence study questionnaire reported Result SARS-CoV-2 single-center smell dysfunction study population Symptom Symptoms the mean was collected [DOI] 10.1186/s43163-021-00186-7 PMC 바로가기 [Article Type] Original Article
From asymptomatic to critical illness: decoding various clinical stages of COVID-19Article Published on 2021-12-172022-10-29 Journal: Turkish Journal of Medical Sciences [Category] COVID-19, SARS, [키워드] accompanied Acute heart failure Acute liver injury acute renal failure affected age ARDS Arrhythmias Asymptomatic average Bacterial C-reactive protein changes in Chest Chronic diseases Clinical course Clinical features clinical monitoring Clinical stage Coagulopathy Comorbidities Complication complications cough Course COVID-19 Critical D-dimer develop diarrhea disease disease severity disorders element Fatality rate ferritin Fever Fungal infection groups headache Hospitalized hospitalized patient immunosuppressants Immunosuppressed incidence include Insomnia intensive care Laboratory tests lung damage lymphopenia malaise Mild myalgia myocarditis Neuropsychiatric pathological change Patient patients Pneumonia poor prognosis Prognosis prothrombotic reported resulting risk risk factor Risk factors secondary Sepsis Septic shock Shortness of breath shown sore throat steroid Symptom Symptoms the patient therapy Thromboembolic events undergo venous [DOI] 10.3906/sag-2107-137 PMC 바로가기 [Article Type] Article
Impact of SARS-CoV-2 Genetic Blueprints on the Oral Manifestation of COVID-19: A Case ReportCase Report Published on 2021-12-162022-10-31 Journal: Global Medical Genetics [Category] COVID-19, [키워드] ACE2 ACE2 receptor acute respiratory syndrome Ageusia angiotensin-converting enzyme-2 Anosmia blueprint Case report cause coronavirus coronavirus disease cough COVID-19 dentist diagnosed with COVID-19 diarrhea Diseases Dyspnea fatigue genomic gingival inflammation Impact include life threatening manifestation myalgia nausea oral oral disease oral manifestation pathway Patient physician positive-sense Pyrexia receptor report reported RNA SARS-CoV-2 Symptom symptoms of COVID-19 the disease these symptom Treatment virus viruses [DOI] 10.1055/s-0041-1735538 PMC 바로가기 [Article Type] Case Report
Patient health records and whole viral genomes from an early SARS-CoV-2 outbreak in a Quebec hospital reveal features associated with favorable outcomesResearch Article Published on 2021-12-022022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] Analysis association clinical feature clinical outcomes COVID-19 data-driven early stage feature genomic headache Health hospital hospitals Lineage Local Mutation myalgia Nanopore Nasopharyngeal swab occurred outbreak outcome outcomes pandemic pangolin Patient performed positive sample predominant Protein Quebec, Canada reduction replicates SARS-CoV-2 Sequencing significantly sore throat subclade Symptom the Spike Transmission viral genome whole genome [DOI] 10.1371/journal.pone.0260714 PMC 바로가기 [Article Type] Research Article
Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort복막 투석 환자에서 mRNA-1273 SARS-CoV-2 백신 접종 후 항체 반응 및 안전성 – 비엔나 코호트Immunology Published on 2021-12-022022-09-12 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] acute respiratory syndrome adverse event analyzed anti-SARS-CoV-2 Anti-SARS-CoV-2 S antibody Antibody Response Antibody titer Antibody titers Clinical course Cohort coronavirus COVID-19 dialysis dose early immune response examined Factor fatigue Fever first dose headache Hemodialysis high risk incidence Infection injection IQR joint Local Lower median Moderna mRNA-1273 mRNA-1273 vaccine mRNA-based myalgia occurred Pain Patient patients Peritoneal dialysis Regression model reported response Result retrospective Safety SARS-CoV-2 SARS-CoV-2 S score second dose Serious Adverse Events seroconversion rate seroconverted severity significantly spike systemic systemic AE systemic side effect vaccination Vaccine Vienna [DOI] 10.3389/fimmu.2021.780594 PMC 바로가기 [Article Type] Immunology
Disentangling post-vaccination symptoms from early COVID-19Research paper Published on 2021-12-012022-10-04 Journal: EClinicalMedicine [Category] 치료기술, [키워드] 1:1 Asymptomatic AUC, area under the curve bMEM, Bayesian mixed-effect model BMI, Body mass index BNT162b2 ChAdOx1 nCoV-19 chronic CI, Confidence interval clinical information Community Comorbidities conducted cough Council COVID COVID-19 COVID-19 detection COVID-19, Coronavirus disease 2019 criteria Critical CSS CSS, COVID Symptoms Study demographic Department DI, Data invalid Early detection Engineering fatigue Fever finding foundation funding headache heart identifying individual infection control injection IQR, inter quartile range KCL, King's College London LFAT, Lateral flow antigen test Local LR, Logistic Regression Medical Research Council Mobile technology MOST myalgia NHS UK, National Health Service of the United Kingdom O-AZ, Oxford-AstraZeneca adenovirus-vectored vaccine overlap Oxford-AstraZeneca adenovirus-vectored vaccine participant Participants PB, Pfizer-BoiNTech mRNA vaccine Pfizer-BioNTech mRNA vaccine positive post-vaccination symptom presenting Prevent profile prospective observational study public health reduce reported symptom RF, Random forest ROC, Receiver operating curve rtPCR, Reverse transcription polymerase chain reaction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test SARS-CoV-2, Severe acute respiratory syndrome-related coronavirus-2 Science Self-reported symptoms sensitivity Seven severe acute respiratory syndrome‐related coronavirus 2 (SARS-CoV-2) severe acute respiratory syndrome‐related coronavirus 2 (SARS-CoV-2) Side-effect Side-effects Spread Symptom Symptoms systemic symptom tested UK, United Kingdom of Great Britain and Nothern Ireland vaccination were recorded with COVID-19 [DOI] 10.1016/j.eclinm.2021.101212 PMC 바로가기 [Article Type] Research paper
Return to Work, Demographic Predictors, and Symptomatic Analysis Among Healthcare Workers Presenting for COVID-19 Testing: A Retrospective Cohort From a United States Academic Occupational Medicine ClinicInfectious Disease Published on 2021-11-272022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome age CDC change clinic Clinical characteristics coronavirus cough COVID-19 COVID-19 infection COVID-19 test demographic demographics determine Employees fatigue female gender Gender HCW HCWs healthcare worker Healthcare workers identify illness duration Medicine myalgia occupational occupational health Older age positive Predictive predictor presenting prevalent Result retrospective return Return to work Risk scores SARS-CoV-2 significant difference symptom onset tested the mean United State was performed with COVID-19 work worker [DOI] 10.7759/cureus.19944 PMC 바로가기 [Article Type] Infectious Disease
COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against VaccinationArticle Published on 2021-11-252022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adverse event AEs age Anxiety approved arterial chronic chronic thromboembolic pulmonary hypertension COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional disease examined Factor fatigue female Fever first dose General population headache identify impacted incidence of COVID-19 Infection injection median age mortality rate much higher myalgia older patient PAH Pain Patient patients post-vaccination symptoms profile pulmonary pulmonary arterial hypertension pulmonary hypertension reason regression analysis reported Safe Safety safety profile second dose thromboembolic Univariate analysis vaccinated against COVID-19 vaccination vaccination against COVID-19 [DOI] 10.3390/vaccines9121395 PMC 바로가기 [Article Type] Article
Evaluation of human coronavirus OC43 and SARS‐COV‐2 in children with respiratory tract infection during the COVID‐19 pandemicResearch Article Published on 2021-11-242022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 치료기술, [키워드] acute respiratory syndrome center Characteristics children Contact coronavirus coronavirus disease Coronaviruses COVID‐19 determine distribution edema Endemic evaluate Fever flexible Frequency HCoV‐OC43 headache human coronavirus human coronavirus OC43 Infection Iran Lymphocyte count median mild respiratory symptoms myalgia OC43 pandemic Patient performed positive positive PCR recruit regions Research respiratory symptom respiratory tract infection responsible RT‐PCR SARS‑CoV2 SARS‐CoV‐2 significant difference significantly higher significantly lower Tehran two group Two patient viruses vomiting [DOI] 10.1002/jmv.27460 PMC 바로가기 [Article Type] Research Article